TWD
MYGN icon

True Wealth Design’s Myriad Genetics MYGN Stock Holding History

True Wealth Design’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
2,126
+1,019
+92% +$4.63K ﹤0.01% 995
2026
Q1 		$4.98K Sell
1,107
-342
-24% -$1.78K ﹤0.01% 1212
2025
Q4 		$8.91K Buy
1,449
+74
+5% +$537 ﹤0.01% 903
2025
Q3 		$9.94K Sell
1,375
-339
-20% -$2.01K ﹤0.01% 835
2025
Q2 		$9.1K Buy
1,714
+1,116
+187% +$6.59K ﹤0.01% 617
2025
Q1 		$5.3K Buy
598
+480
+407% +$5.76K ﹤0.01% 667
2024
Q4 		$1.62K Buy
+118
New +$2.18K ﹤0.01% 793

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

True Wealth Design's MYGN Position: Q2 2026 in Review

True Wealth Design increased its Myriad Genetics (MYGN) stake by 92% in Q2 2026, buying an estimated $4.63K and bringing the position to 2,126 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

True Wealth Design first reported a position in MYGN in Q4 2024 and has held it in 7 quarters since. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • True Wealth Design held 2,126 shares of Myriad Genetics worth $12.1K as of Q2 2026.
  • True Wealth Design bought 1,019 Myriad Genetics shares in Q2 2026, an estimated $4.63K.
  • Myriad Genetics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #995 holding.
  • True Wealth Design first reported a position in Myriad Genetics in Q4 2024 and has held it in 7 quarters since.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.